Potassium Acetate Injection Shortage

• • Potassium acetate injection, American Regent, 2 mEq/mL, 20 mL vial, 25 count, NDC 00517-2053-25
  • Potassium acetate injection, American Regent, 4 mEq/mL, 50 mL vial, 25 count, NDC 00517-5024-25

• • American Regent has potassium acetate on long-term shortage due to manufacturing delays. It is unclear if and when product will return to market
  • Pfizer has potassium acetate injection available.
  • Exela received FDA approval for potassium acetate injection in late-December 2015. Exela has potassium acetate injection available.

• • Potassium acetate injection, Exela Pharma Sciences, 2 mEq/mL, 20 mL vial, 25 count, NDC 51754-2001-04
  • Potassium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-8183-01
  • Potassium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3924-51

Estimated Resupply Dates

• • American Regent has potassium acetate 2 mEq/mL 20 mL vials and 4 mEq/mL 50 mL vials on long-term back order and the company cannot estimate a release date.
  • All other marketed presentations are available.